276 related articles for article (PubMed ID: 36142860)
1. Dynamics of Inflammatory and Neurodegenerative Biomarkers after Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
Ruder J; Dinner G; Maceski A; Berenjeno-Correa E; Müller AM; Jelcic I; Kuhle J; Martin R
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142860
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus and Monoclonal Gammopathy of Clinical Significance in Autologous Stem Cell Transplantation for Multiple Sclerosis.
Mehra V; Rhone E; Widya S; Zuckerman M; Potter V; Raj K; Kulasekararaj A; McLornan D; de Lavallade H; Benson-Quarm N; Lim C; Ware S; Sudhanva M; Malik O; Nicholas R; Muraro PA; Marsh J; Mufti GJ; Silber E; Pagliuca A; Kazmi MA
Clin Infect Dis; 2019 Oct; 69(10):1757-1763. PubMed ID: 30980715
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis.
Robinson T; Abdelhak A; Bose T; Meinl E; Otto M; Zettl UK; Dersch R; Tumani H; Rauer S; Huss A
Cells; 2020 Nov; 9(12):. PubMed ID: 33255854
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis.
Zjukovskaja C; Larsson A; Cherif H; Kultima K; Burman J
Mult Scler Relat Disord; 2022 Dec; 68():104210. PubMed ID: 36257151
[TBL] [Abstract][Full Text] [Related]
5. Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis.
Massey J; Artuz C; Dyer Z; Jackson K; Khoo M; Visweswaran M; Withers B; Moore J; Ma D; Sutton I
Clin Immunol; 2023 Sep; 254():109709. PubMed ID: 37495004
[TBL] [Abstract][Full Text] [Related]
6. CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Lundblad K; Zjukovskaja C; Larsson A; Cherif H; Kultima K; Burman J
Neurol Neuroimmunol Neuroinflamm; 2023 Sep; 10(5):. PubMed ID: 37311645
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid mtDNA concentrations are increased in multiple sclerosis and were normalized after intervention with autologous hematopoietic stem cell transplantation.
Pavlovic I; Zjukovskaja C; Nazir FH; Müller M; Wiberg A; Burman J
Mult Scler Relat Disord; 2024 Apr; 84():105482. PubMed ID: 38341978
[TBL] [Abstract][Full Text] [Related]
8. Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients.
Vaivade A; Wiberg A; Khoonsari PE; Carlsson H; Herman S; Al-Grety A; Freyhult E; Olsson-Strömberg U; Burman J; Kultima K
Lipids Health Dis; 2023 Jul; 22(1):97. PubMed ID: 37420217
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.
Novakova L; Axelsson M; Khademi M; Zetterberg H; Blennow K; Malmeström C; Piehl F; Olsson T; Lycke J
Mult Scler; 2017 Jan; 23(1):62-71. PubMed ID: 27003946
[TBL] [Abstract][Full Text] [Related]
10. A Score Based on NfL and Glial Markers May Differentiate Between Relapsing-Remitting and Progressive MS Course.
Huss A; Otto M; Senel M; Ludolph AC; Abdelhak A; Tumani H
Front Neurol; 2020; 11():608. PubMed ID: 32765393
[No Abstract] [Full Text] [Related]
11. Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis.
Mariottini A; Marchi L; Innocenti C; Di Cristinzi M; Pasca M; Filippini S; Barilaro A; Mechi C; Fani A; Mazzanti B; Biagioli T; Materozzi F; Saccardi R; Massacesi L; Repice AM
Front Neurol; 2022; 13():820256. PubMed ID: 35280289
[TBL] [Abstract][Full Text] [Related]
12. Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant.
Massey J; Visweswaran M; Khoo M; Hendrawan K; Sutton I; Withers B; Ma D; Moore J
Cytotherapy; 2023 Dec; 25(12):1271-1276. PubMed ID: 37737765
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of T cell repertoire renewal following autologous hematopoietic stem cell transplantation in multiple sclerosis.
Ruder J; Docampo MJ; Rex J; Obahor S; Naghavian R; Müller AMS; Schanz U; Jelcic I; Martin R
Sci Transl Med; 2022 Nov; 14(669):eabq1693. PubMed ID: 36322629
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation.
Hendrawan K; Khoo MLM; Visweswaran M; Massey JC; Withers B; Sutton I; Ma DDF; Moore JJ
Front Immunol; 2021; 12():782935. PubMed ID: 35126353
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis.
Larsson D; Åkerfeldt T; Carlson K; Burman J
Mult Scler; 2020 Oct; 26(11):1351-1359. PubMed ID: 31347948
[TBL] [Abstract][Full Text] [Related]
16. Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis.
Massey J; Jackson K; Singh M; Hughes B; Withers B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I
Front Immunol; 2022; 13():798300. PubMed ID: 35197974
[TBL] [Abstract][Full Text] [Related]
17. Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity.
Högel H; Rissanen E; Barro C; Matilainen M; Nylund M; Kuhle J; Airas L
Mult Scler; 2020 Feb; 26(2):210-219. PubMed ID: 30570436
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL.
Ding Y; Ru Y; Song T; Guo L; Zhang X; Zhu J; Li C; Jin Z; Huang H; Tu Y; Xu M; Xu Y; Chen J; Wu D
Ann Hematol; 2021 Nov; 100(11):2773-2785. PubMed ID: 34480615
[TBL] [Abstract][Full Text] [Related]
19. Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantation.
Gernert M; Tony HP; Schwaneck EC; Fröhlich M; Schmalzing M
Arthritis Res Ther; 2020 Aug; 22(1):183. PubMed ID: 32771029
[TBL] [Abstract][Full Text] [Related]
20. Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis.
Kasarełło K; Snarski E; Sulejczak D; Ciesielski T; Wiśniewska A; Wrzesień R; Cudnoch-Jędrzejewska A
Arch Immunol Ther Exp (Warsz); 2021 Jun; 69(1):17. PubMed ID: 34181099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
